Anemia is usually thought of as a fatigue and weakness issue, the kind of diagnosis that shows up on a routine blood test and gets treated with iron supplements. A new study suggests the condition may carry a far more serious long term risk, one tied directly to dementia and Alzheimer’s disease.
The research, published in JAMA Network Open, followed more than 2,200 adults age 60 and older who showed no signs of dementia at the outset. Using data from the Swedish National Study on Aging and Care in Kungsholmen, researchers tracked participants for an average of 9.3 years, testing blood samples for hemoglobin levels alongside biomarkers associated with Alzheimer’s disease.
What the Study Found
Participants with low iron showed notably higher levels of Alzheimer’s related biomarkers than those with normal hemoglobin levels. Overall, people with anemia had a 66% higher risk of developing dementia during the study period. That risk held up even after researchers excluded participants who developed mild cognitive impairment or dementia within the first six years of follow up, suggesting the association was not simply an early warning sign of cognitive decline already underway.
About 8.7% of participants had anemia at the study’s start. Those individuals tended to be older, more often male, and more likely to have lower levels of education and a higher burden of chronic disease overall. Researchers also found the connection between anemia and dementia risk was more pronounced in men, pointing to a possible sex based difference in how the condition affects the brain over time.
Why Researchers Think the Link Matters
An Alzheimer’s Association researcher not involved in the study noted that while earlier research had hinted at a connection between anemia and dementia, this study adds meaningful depth by tying anemia directly to specific Alzheimer’s related blood biomarkers rather than relying on dementia diagnoses alone.
The study’s lead author emphasized a practical angle, pointing out that anemia is easy to detect through routine blood work and is often treatable. That combination makes it a potentially useful, modifiable factor for clinicians evaluating dementia risk in older patients, even though researchers stopped short of claiming that treating anemia would directly prevent dementia from developing.
What the Study Cannot Tell Us
Despite the strength of the association, several limitations temper how the findings should be read. The study population was overwhelmingly white and drawn from a single region in Sweden, which limits how broadly the results can be applied to other populations. The research was also observational, meaning it can identify a strong statistical relationship without proving that anemia directly causes dementia. Missing data and the inherent difficulty of accurately diagnosing dementia in large study populations add further uncertainty.
What This Could Mean Going Forward
Researchers suggest that anemia could become a useful marker in cognitive health assessments, particularly for older adults who present with early memory concerns. Rather than treating anemia as an isolated, minor condition, healthcare providers may want to factor it into broader evaluations of dementia risk, prompting closer monitoring for patients who show both anemia and early cognitive changes.
The study does not suggest that anemia alone predicts dementia, and researchers caution that meaningfully more work is needed before anemia treatment could be considered a dementia prevention strategy in its own right. For now, the findings add a data point that may help clinicians think more carefully about a condition that is common, inexpensive to detect and often manageable, but potentially more consequential for long term brain health than previously understood.
This article discusses ongoing medical research and is not medical advice. Anyone with concerns about anemia, memory changes, or dementia risk should speak with a healthcare provider.
